CLL / SLL
Clinical trials for CLL / SLL explained in plain language.
Never miss a new study
Get alerted when new CLL / SLL trials appear
Sign up with your email to follow new studies for CLL / SLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells get a boost: new combo therapy targets Hard-to-Treat blood cancers
Disease control OngoingThis early-phase trial tests a new approach to treating certain blood cancers (like lymphoma and leukemia) that have come back or not responded to standard treatment. The therapy uses a patient's own immune cells, engineered to recognize and attack cancer cells (SYNCAR-001), alon…
Matched conditions: CLL / SLL
Phase: PHASE1 • Sponsor: Synthekine • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
French study tracks Real-World CLL care to improve patient outcomes
Knowledge-focused OngoingThis study follows 1,000 people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in France to see how they are actually treated in everyday clinics, not just in controlled trials. Researchers will track which therapies patients receive, in what order, a…
Matched conditions: CLL / SLL
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC